Sarah Hussein, Ph.D.

Sarah Hussein is an accomplished Egyptian virologist specializing in influenza and SARS-CoV-2 viruses. Armed with a robust academic background spanning biotechnology, and bioinformatics, she attained her doctoral degree by pioneering research focused on predicting and assessing the interaction of influenza A viruses with mammals through computational methods.

Sarah has built a robust career at the Center of Scientific Excellence for Influenza Viruses (CSEIV) within Cairo's National Research Centre (NRC), Egypt. Starting as a Research Assistant, she now holds the role of a Postdoctoral Researcher. Her diverse portfolio encompasses validating drug designs, conducting preclinical assessments, and strategizing vaccines for influenza A and SARS-CoV-2 viruses. Beyond research, Sarah actively contributes to professional societies like the American Society of Microbiology and the Egyptian Society of Virology. She collaborates internationally, evaluating antiviral activities, vaccination strategies, and diagnostic tools for influenza A and SARS-CoV-2. Her influence extends outside the lab through organizing scientific events, global conference participation, and teaching bioinformatics to undergraduates. With a prolific research background, she's developed diagnostic kits, vaccine candidates, and therapies for various viral infections."

Driven by an ardent passion for virology and infectious diseases, Sarah's research focal points encompass unraveling the evolution, pathogenesis, and prevention/control of zoonotic viruses. Her tireless dedication aims to bridge scientific knowledge with practical solutions, making significant strides in combatting infectious diseases worldwide.